Louise Mehrotra Vice President Investor Relations
|
|
- Ashley Bradford
- 5 years ago
- Views:
Transcription
1
2 Louise Mehrotra Vice President Investor Relations
3 Safe Harbor Statement This presentation may contain forward-looking statements as defined in the Private Securities Litigation Reform Act of These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company s expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 to the Company s Annual Report on Form 10-K for the fiscal year ended December 30, Copies of this Form 10-K, as well as subsequent filings, are available online at or on request from the Company. The Company does not undertake to update any forward-looking statements as a result of new information or future events or developments.
4 Michael Mahoney Company Group Chairman - DePuy
5 Today s Agenda DePuy Franchise Mike Mahoney Company Group Chairman DePuy Orthopaedics David Floyd President - DePuy Orthopaedics DePuy Spine Gary Fischetti WW President - DePuy Spine DePuy Trauma Gordon Van Ummersen & Extremities General Manager - Trauma & Extremities DePuy Mitek Mike McBreen VP Sales; General Manager ORTHOVISC DePuy Mitek
6 Orthopaedic market Highlights Strong and relatively stable DePuy The market leader and gaining momentum Executing an innovative pipeline Entering into new high growth segments Global scale and growth
7 EARLY INTERVENTION INTERMEDIATE INTERVENTION ARTHROPLASTY TRAUMA SPINAL AND NEUROLOGICAL DISORDERS
8 DePuy Franchise Sales YE 2007 Operational Growth 2007 Market Position 2007* $4.6B 8.4% #1 DePuy Orthopaedics #1 share in US hips *Internal Estimates DePuy Trauma DePuy Spine DePuy Mitek Codman Hand Innovations acquisition fueling growth Enhanced US sales network, Disc-O-Tech acquisition Double-digit growth in core business and new business segments (FMS, Orthovisc ) Solid international growth
9 2007 Wrap Up: WW Results Strong Quarterly Growth Trend & Faster Than Market in Most Segments Q1 Q4 Quarterly Sales Trend DePuy WW Market Share Operational DePuy Growth Market Growth (Int Est) Hips Knees Trauma Spine Sports Neuro /3 2 12% 9% 8% 9% 26%* 11% 7% 12% 18% 8% 5% 3% Above Market Below Market *Excludes sales to Japanese trauma distributor
10 Product Launches Hips GRIPTION coating ULTAMET XL Metal-on-Metal Bearings COMPEL (OUS) Knees Ci Essential Computer Assisted Surgery Mobile Bearing Revision Enhancements Shoulder GLOBAL AP Shoulder DELTA Xtend Reverse Shoulder 2007: More than 20 New Product Launches/3 PMAs Selected Technologies Trauma PEAK FX SNP Shoulder Nail Plate F3 Fragment Plating System Spine EXPEDIUM 6.35 Rod and Screw System CONCORDE Bullet VIPER 2 Sports Medicine BioknotlessBP/Lupine BR Fluid Management - VAPR S 50 PMAs Submitted Articular Surface Replacement Hip Ceramic-on-Ceramic Hip MEDSTREAM Programmable Infusion Pump
11 Orthopaedic Market Trends Increasing patient demand Less invasive procedures MIS Global expansion/developing markets Changing compliance landscape Increasing economic influence: reimbursement and pricing
12 DePuy Growth Strategies Portfolio execution: leading and innovative Early intervention/mis Solutions to improve customer productivity Continue to expand into new and high growth segments Global market expansion
13 Over 25 New Products HEALIX DePuy ASR TRI-LOCK CONFIDENCE SIGMA/LCS Enhancements ALPS CAIS (OUS)
14 David Floyd President DePuy Orthopaedics, U.S.
15 Joints Market Hips Knees 2007 Sales Growth* 12% 8% 2007 Market Position 2 2 WW Recon Market CAGR** 7% 8% WW Projected Total Market Revenue** $7.5B $9.0B Growth Drivers: *Operational **Internal Estimates Favorable demographics Earlier intervention/less invasive Innovative new products
16 Growth Strategies: Hip Introduce a steady cadence of new product offerings High performance bearings Tissue-sparing, bone preserving stems Promote anterior approach Sustain tribology leadership
17 Growth Strategies: Hip Focus on emerging markets Target younger and more active patients Educate through direct-to-patient communication
18 Hip Portfolio Biolox Delta DePuy ASR AltrX LD Proxima Corail ASR XL Ceramax Ceramic-on-Ceramic TRI-LOCK Gription Coating Pinnacle Acetabular Cup Ultamet XL Summit Hip System AltrX S-ROM Hip System Marathon AML Hip System
19 TRI-LOCK with Anterior Approach GRIPTION fixation technology improves stability Bone preserving stem Smaller incision for minimally invasive surgery with anterior approach Faster recovery
20 BHR ASR Advanced Tribology Advanced Fixation Advanced Bone Preservation Articular Surface Replacement Advanced Biomechanics Advanced Instrumentation
21 Growth Strategies: Knee Target broad-based patient needs with more personalized knee solutions Enhanced portfolio with wide range of sizes, shapes and advanced materials New instrumentation Introduce steady cadence of new products More than 10 product introductions over the next 18 months Professional education to support introduction of new instruments and products Direct-to-patient communication
22 CR Porocoat Ci Essential Sigma HP Partial Knee RP-F Sigma HP Instruments Sigma CR F TC3 RP Sigma Sizes Sigma AO Poly* Sigma PS Femur Sigma Fixed Bearing * In development
23 Porocoat HP Ci Essential HP Instruments LCS RPS Flexion LCS Duofix LCS RP HP Poly* Complete Revision * In development
24 Advanced surgical instrumentation Largest DePuy introduction in last 10 years Benefits: Efficiency, Precision, Flexibility Optimizes computer assisted and manual surgery
25 Patient outreach to connect patients to surgeons who use DePuy products: National print advertising Online marketing Web education/surgeon locator Local patient education events
26 In Conclusion Sustaining leadership position in hips with cadence of new products Expanding knee portfolio with series of new products and instrumentation Educating patients through direct-to-consumer communication
27 Gary Fischetti WW President DePuy Spine
28 DePuy Spine Poised for Growth Core portfolio continues to show strength and consistent growth Realigned and invested in distributor network 8 new products in 2007 Investments in new and adjacent key growth markets Continued momentum in international markets DISCOVER, EXPEDIUM, MOUNTAINEER, SKYLINE
29 Spine Market 2007 Sales Growth* 7% 2007 Market Position 2 WW Market Opportunity CAGR** 9% WW Projected Total Market Revenue 2012** $11B Today s Spine Market is Dynamic New technologies and procedures will drive growth Growing aging population Increasing adoption and access in OUS markets *Operational Growth **Internal Estimates Challenges Insurance coverage and reimbursement issues remain Higher costs and data requirements for bringing new technology to market Changing compliance landscape
30 2008 Additions to Core Portfolio Complex Spine Minimally Invasive Surgery Cervical X-MESH * MOUNTAINEER EXPEDIUM 4.5 BENGAL Stackable* VIPER 2 EXPEDIUM PEEK Rods* VG1 Cervical * EAGLE / SWIFT + *Not yet available for market release
31 DePuy Spine Investing in new and adjacent key growth markets NEW MARKETS Genetic Based Diagnostics with Axial Biotech Annular Repair with Biomerix Facet Replacement ADJACENT MARKETS Posterior Dynamic Stabilization Represents the next evolution of spinal treatments Part of EXPEDIUM System Incorporates flexible nitinol rod VCF with CONFIDENCE
32 Strategic Fit CONFIDENCE Spinal Cement System DePuy Spine enters new >$500 Million high growth segment Central to our aging spine portfolio Features Controlled Delivery of Highly Viscous Cement Reduced Radiation Exposure Streamlined Procedure with Reduced Steps Seamless Mixing and Transfer of Cement
33 DePuy Spine Poised for Growth Core portfolio continues to show strength and consistent growth Investments in new and adjacent key growth markets Continued momentum in international markets Well positioned for dynamic marketplace
34 Gordon Van Ummersen General Manager WW Trauma and Extremities
35 Trauma Market 2007 Sales Growth* 26%** 2007 Market Position 4 WW Market Opportunity CAGR*** 9% WW Projected Total Market Revenue 2012*** $5B Growth Drivers *Operational **Excludes sales to Japanese trauma distributor ***Internal Estimates Among fastest growing areas in medical devices Predictable patient population, favorable demographics New technology driving more procedures Reimbursement and positive pricing trends Under penetrated global markets
36 DePuy Orthopaedics, Inc. Trauma Significant Investment in Trauma Building on Successful Hand Innovations Acquisition Enhanced Commercial Capabilities
37 DePuy Orthopaedics Inc. Trauma Winning Capabilities TM
38 Small Fragment Set Launched Feb Large Fragment Set* Launch = Mar-Apr Elbow System* FDA Sub = Q2 Q Q Q Q Ankle System* Launch = Mar-Apr Proximal Tibia Set* FDA Sub = Q2 Foot System* FDA Sub = Q4 *Pending approval in U.S.
39 DePuy Orthopaedics, Inc. Extremities Building on WW Leadership Position in Shoulder/Ankle Markets DELTA Xtend, GLOBAL AP and AGILITY LP
40 Mike McBreen VP US Sales; General Manager ORTHOVISC DePuy Mitek
41 Sports Medicine Market 2007 Sales Growth* 2007 Market Position WW Market CAGR** WW Projected Total Market Revenue** 18% 2 9% $3.5B Growth Drivers *Operational **Internal Estimates Fastest growing fellowship area 30% of Orthopaedic fellowships are Sports Medicine Active population with increasing expectations Under developed global markets Less invasive surgical approaches Focus on innovation (absorbable materials, biologics)
42 Growth Strategies Gateway to orthopaedic care for DePuy Franchise Leverage global distribution capabilities Expand surgeon training Capitalize on proprietary material innovation in BIOCRYL RAPIDE TM Invest in OA disease state through ORTHOVISC Viscosupplement Expand leadership positions through portfolio enhancements
43 Arthroscopic Shoulder Repair Broad DePuy Mitek portfolio, strong position 400,000 Rotator Cuff surgeries in US annually* HEALIX TM PEEK Suture Anchor System Bone specific threads to reduce risk of anchor pull-out US Launched AAOS International mid 2008 *AAOS Estimates
44 Over 100,000 ACL repairs annually* FEMORAL INTRAFIX ACL Fixation System Anatomical ACL reconstruction US Launched AAOS Internationally Mid 2008 ACL Repair *AAOS Estimates
45 DePuy Key Summary Points Orthopaedic market Strong and relatively stable DePuy The market leader and gaining momentum Executing an innovative pipeline Entering into new high growth segments Global scale and growth
46
47
First Albany Orthopedics Conference Marina Village, San Diego February 13, 2007 Orthofix International
First Albany Orthopedics Conference Marina Village, San Diego February 13, 2007 Orthofix International Tom Hein, CFO Safe Harbor Statement Except for historical information contained herein, the statements
More informationOrthopaedics Business. Dave Illingworth, President February
Orthopaedics Business Dave Illingworth, President February 23 2005 1 Smith & Nephew Orthopaedics Attractive market Strong performance Momentum 2 Attractive market Demographics - 2x Growth by 2020 Active
More informationJOINT RECONSTRUCTION PORTFOLIO OVERVIEW
JOINT RECONSTRUCTION PORTFOLIO OVERVIEW At DePuy Synthes Companies, we are inspired by you. DEPUY SYNTHES JOINT RECONSTRUCTION Uniquely focused on understanding today s opportunities and tomorrow s DePuy
More informationOptimum implant geometry
Design Rationale Optimum implant geometry Extending proven Tri-Lock heritage The original Tri-Lock was introduced in 1981. This implant was the first proximally coated tapered-wedge hip stem available
More informationOptimum implant geometry
Design Rationale Optimum implant geometry Extending the proven Tri-Lock heritage The original Tri-Lock was introduced in 1981. This implant was the first proximally coated tapered-wedge hip stem available
More informationTable of Contents: JULY TH EDITION
Table of Contents: Table of Contents of the worldwide Orthopaedic Contract manufacturing Market 2016-2021 & Top 100 player profiles 275+ pages 450+ exhibits July 2017 5 th edition I- Worldwide orthopaedic
More informationMerck Announces FDA Approval of KEYTRUDA. Provided to Investors as a Reference
Merck Announces FDA Approval of KEYTRUDA Provided to Investors as a Reference Forward-Looking Statement This presentation includes forward-looking statements within the meaning of the safe harbor provisions
More informationUnderstanding Hip Implant Options
Understanding Hip Implant Options Cup (Socket) Bearing (Liner) Head Stem (Femur) Modern Hip Implants (Ball) Metal Femoral Head on Marathon Cross-linked Polyethylene Liner Proven materials Polyethylene
More informationBone Preservation Stem
TRI-LOCK Bone Preservation Stem Featuring GRIPTION Coating Surgical Technique Implant Geometry Extending the TRI-LOCK Stem heritage The original TRI-LOCK Stem was introduced in 1981. This implant was
More informationMAKO Surgical Corp. January MAKO Surgical Corp
MAKO Surgical Corp. January 2012 MAKO Surgical Corp. 2012 1 Forward Looking Statement This presentation contains forward-looking statements regarding, among other things, statements related to expectations,
More information34 th Annual J.P. Morgan Healthcare Conference
JANUARY 2016 34 th Annual J.P. Morgan Healthcare Conference [ 1 ] Forward Looking Statements SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS In addition to historical information, this presentation contains
More informationVisionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics
Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce
More informationCorporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015
(Nasdaq:EVAR) Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015 Safe Harbor This presentation contains forward-looking statements as that term is defined in the Private Securities Litigation
More informationSAMPLE. South Korea Orthopedic Procedures Outlook to Reference Code: GDMEMC0008PDB. Publication Date: March 2014
South Korea Orthopedic Procedures Outlook to 2020 Reference Code: GDMEMC0008PDB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...
More informationSolutions For The Aging Spine
Solutions For The Aging Spine NASDAQ: ATEC February 2009 www.alphatecspine.com Slide 0 5818 El Camino Real, Carlsbad, CA 92008 www.alphatecspine.com Forward Looking Statements This presentation and our
More informationAmy Hendrickson Complaint/M DR Administrator DePuy Johnson & Johnson Phone: x 7179 Fax:
From: To: CC: Sent: Subject: Hendrickson, Amy [DPYUS] Cary, Polly [DPYUS) Reimink, Matt [DPYUS] 12/ 19/2008 3:21:21 PM FW: ASR XL metal bearings demonstrated 99.2% survivorship at 3 years does NOT match
More informationJanuary 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More informationST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015
ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationDelivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental
Delivering Results POSITIONED FOR GROWTH Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental PAUL GUGGENHEIM CEO, Patterson Dental Former owner and president, Guggenheim Brothers
More informationChina Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020
China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020 Reference Code: GDMECC0079DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2
More informationHIP CONTINUUM OF CARE. Trauma and Joint Reconstruction Hip Portfolio
HIP CONTINUUM OF CARE Trauma and Joint Reconstruction Hip Portfolio TABLE OF CONTENTS HIP CONTINUUM OF CARE Overview 4 Portfolio Highlight 6 PRODUCT SOLUTIONS Pelvic Fractures 10 Femoral Neck Fractures
More informationSlide 1. Welcome and strategy update. Lars Fruergaard Jørgensen President and CEO
Slide 1 Lars Fruergaard Jørgensen President and CEO Slide 2 Forward-looking statements Novo Nordisk s reports filed with or furnished to the US Securities and Exchange Commission (SEC), including the company
More informationThe Leader in Orthopaedic Innovation
The Leader in Orthopaedic Innovation Wright is a leading international manufacturer and distributor of superior, easy to use, and innovative orthopaedic implants and instrumentation. For over 50 years,
More informationSlide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes
Slide 1 International Operations update Mike Doustdar EVP International Operations YASMIN FIEDLER, Germany Yasmin has type 1 diabetes Slide 2 Forward-looking statements Novo Nordisk s reports filed with
More informationSlide 1. Welcome and introduction. Lars Rebien Sørensen President & CEO
Slide 1 Lars Rebien Sørensen President & CEO Slide 2 Capital Markets Day 2015 Slide 3 Forward-looking statements Novo Nordisk s reports filed with or furnished to the US Securities and Exchange Commission
More information36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018
36th Annual J.P. Morgan Healthcare Conference Kevin Conroy, Chairman and CEO January 9, 2018 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section
More informationGenomic Health. Kim Popovits, Chairman, CEO and President
Genomic Health Kim Popovits, Chairman, CEO and President Safe Harbor Statement Various remarks that we make in this presentation that are not historical, including those about our future financial and
More informationJanuary 2017 Investor Presentation. confidently live life with ease
January 2017 Investor Presentation confidently live life with ease Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that could
More informationForward-looking Statement Disclaimer
Forward-looking Statement Disclaimer This presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to
More informationTransparency Market Research
Transparency Market Research IGBT and Super Junction MOSFET Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: USD 4595 Multi User License: USD
More informationNASDAQ: ELGX December Innovation that Empowers
NASDAQ: ELGX www.endologix.com December 2014 Innovation that Empowers Safe Harbor This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act
More informationAgreement to Acquire Spinal Kinetics, Inc. March 15, 2018
Agreement to Acquire Spinal Kinetics, Inc. 1 March 15, 2018 2 SAFE HARBOR STATEMENT AND USE OF NON GAAP MEASURES WHY SPINAL KINETICS? The Spinal Kinetics M6 artificial discs further round out Orthofix
More informationAstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes
AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance Becoming Global Leaders In Diabetes 19th December 2013 Cautionary Statement Regarding Forward-Looking Statements In order,
More informationOptimum implant geometry
Surgical Technique Optimum implant geometry Extending proven Tri-Lock heritage The original Tri-Lock was introduced in 1981. This implant was the first proximally coated tapered-wedge hip stem available
More informationLifeHealthcare Investor Day 5 October 2016
LifeHealthcare Investor Day 5 October 2016 Agenda 1. Lunch and Welcome 2. LifeHealthcare Overview and Update on Strategic Priorities 3. Spine Overview 4. Dr Hsu Presentation 5. Orthopaedics Overview 6.
More informationFood & Beverages Food for a growing world
Food & Beverages Food for a growing world Rasmus von Gottberg, Vice President F&B Marketing, Novozymes Christel Thea Jørgensen, Vice President R&D, Novozymes Jeremy Bentham, Go to Market Director, Cargill
More informationQiG INS Conference May 22, 2011
Strategy & Vision Growth Electrochem Medical Device Evolution QiG Cardio vascular QiG INS Conference May 22, 2011 Greatbatch Medical Neuro modulation 1 GREATBATCH TODAY 2010 Revenue by Product Line NYSE:
More informationChina Orthopedics Implants Medical Devices Market Brief
China Orthopedics Implants Medical Devices Market Brief By: PIM LTD. August 2017 reproduced for distribution outside the client organization without prior written approval from PIM Ltd. 1 Definition and
More information2015 Investor Conference
2015 Investor Conference ACCELERATING PROFITABLE GROWTH Jill Schaaf President, Renal Care Teeramanas Tanaekakarapong, ESRD Patient, Bangkok, Thailand Becoming The Global Leader In Renal Care Our Global
More informationAnnual Stockholder Meeting May 30, confidently live life with ease
Annual Stockholder Meeting May 30, 2018 confidently live life with ease Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that
More informationFeaturing. Technology. Product Rationale
Featuring Technology Product Rationale 2 Optimum implant geometry Extending proven TRI-LOCK heritage The original TRI-LOCK Stem was introduced in 1981. This implant was the first proximally coated tapered-wedge
More informationInvestor Day LA&C Region Lausanne, September 29, Jeanne Pollès President, Latin America & Canada Region
Investor Day LA&C Region Lausanne, September 29, 2016 Jeanne Pollès President, Latin America & Canada Region Agenda Regional Overview and Performance Regional Strategies Key Markets Conclusion 2 LA&C Regional
More informationDEPUY SYNTHES SOLUTIONS
DEPUY SYNTHES SOLUTIONS This publication is not intended for distribution in the USA. PRODUCT PORTFOLIO At DePuy Synthes Companies, we are inspired by you. DEPUY SYNTHES JOINT RECONSTRUCTION Uniquely focused
More informationMedSurg: Endoscopy Presentation for the Investment Community at DDW. Art Butcher Senior Vice President and President, Endoscopy
MedSurg: Endoscopy Presentation for the Investment Community at DDW Art Butcher Senior Vice President and President, Endoscopy Safe Harbor for Forward-Looking Statements This presentation contains forward-looking
More informationForward Looking Statements and Further Information
JANUARY 2015 [ 1 ] Forward Looking Statements and Further Information SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements. All statements other than
More informationPresentation to 2019 JP Morgan Healthcare Conference
For immediate release 10 January 2019 Presentation to 2019 JP Morgan Healthcare Conference Please find attached CSL Limited s presentation at the 2019 JP Morgan Healthcare Conference. For further information,
More informationSlide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A
Slide 1 Financial update and closing remarks Jesper Brandgaard EVP and CFO RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A Slide 2 Forward-looking statements Novo Nordisk s reports filed with or
More informationDiagnostics for the early detection and prevention of colon cancer. Fourth-Quarter 2014 Earnings Call February 24, 2015
Diagnostics for the early detection and prevention of colon cancer Fourth-Quarter 2014 Earnings Call February 24, 2015 Safe Harbor Statement Certain statements made in this presentation contain forward-looking
More information- Plans Commercial Launch of three dosing options for Excellagen in pre-filled syringes
Generex Biotechnology Subsidiary Olaregen Therapeutix Inc. Plans Launch of FDA Cleared Excellagen Wound Conforming Gel Matrix with Three Dosage Options - Plans Commercial Launch of three dosing options
More informationTranscatheter Aortic Valve Replacement. Larry L. Wood Corporate Vice President
Transcatheter Aortic Valve Replacement Larry L. Wood Corporate Vice President Leader in ~$3.5B Global Transcatheter Aortic Valve Replacement Market Primary global growth drivers: indication expansion,
More informationTOTAL HIP REPLACEMENT:
THR Prosthesis Design TOTAL HIP REPLACEMENT: PROSTHESIS DESIGN FEATURES JESS JOHNSTON & MELINDA ZIETH History of Hip Prosthesis Joint Replacement Registry Implant Design Technology & Future History and
More informationACTIS. TOTAL HIP SYSTEM Approach Active Patients with Confidence DESIGN RATIONALE
ACTIS TOTAL HIP SYSTEM Approach Active Patients with Confidence DESIGN RATIONALE APPROACH ACTIVE PATIENTS WITH CONFIDENCE The ACTIS Total Hip System is the first DePuy Synthes Companies of Johnson & Johnson
More informationAsia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Reference Code: GDMECR0107PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3
More informationExpanding the boundaries of nutrition Luis Cantarell
Expanding the boundaries of nutrition Luis Cantarell Nestlé Investor Seminar 30 September 2013 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationCompany Overview February 26, 2019
Company Overview February 26, 2019 SAFE HARBOR Cautionary Note Regarding Forward-Looking Statements Certain statements in this presentation constitute forward-looking statements, including, without limitation,
More informationMyriad Genetics Corporate Presentation 06/13/2018
Myriad Genetics Corporate Presentation 06/13/2018 Copyright 2016 2018 Myriad Genetics, Inc., all rights reserved. www.myriad.com. 1 Forward Looking Statements Some of the information presented here today
More informationpsivida Transforms into Commercial Stage Specialty BioPharmaceutical Company AAO October 25, 2018 NASDAQ: EYPT
psivida Transforms into Commercial Stage Specialty BioPharmaceutical Company OIS @ AAO October 25, 2018 NASDAQ: EYPT Forward Looking SAFE HARBOR STATEMENTS UNDER THE PRIVATE SECURITIES LITIGATION REFORM
More informationMAKO Surgical Corp. January 2013
MAKO Surgical Corp. January 2013 Forward Looking Statements This presentation contains forward-looking statements regarding, among other things, statements related to expectations, goals, plans, objectives
More informationMERCK ONCOLOGY OVERVIEW ASCO 2018 JUNE 4, 2018
MERCK ONCOLOGY OVERVIEW ASCO 218 JUNE 4, 218 Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA This presentation of Merck & Co., Inc., Kenilworth, N.J., USA (the company ) includes forward
More informationLivaNova Investor Day
LivaNova Investor Day TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR) Paul Buckman General Manager, TMVR September 14, 2017 Safe Harbor Statement Certain statements in this presentation, other than purely
More informationCorporate Presentation
Corporate Presentation January 2019 2018 Chembio. All Rights Reserved. # 2019 Chembio. All Rights Reserved. Page 1 Safe Harbor Statement Statements contained herein that are not historical facts are forward-looking
More informationPatrick J. Sullivan Chief Executive Officer. January 9, 2018 Investor Presentation
Patrick J. Sullivan Chief Executive Officer January 9, 2018 Investor Presentation Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's expectations, anticipations,
More informationFIXATION FIRST WEAR REDUCTION OXIDATIVE STABILITY MECHANICAL INTEGRITY PROVEN TECHNOLOGY
FIXATION FIRST WEAR REDUCTION OXIDATIVE STABILITY MECHANICAL INTEGRITY PROVEN TECHNOLOGY Fixation First FIXATION FIRST 1958 Charnley Hip Over 1,000,000 implanted 1 96.2 percent survivorship at 32 years
More informationLiquid Biopsies. Next Generation Cancer Molecular Diagnostics
Liquid Biopsies Next Generation Cancer Molecular Diagnostics Forward Looking Statements 2 Statements pertaining to future financial and/or operating results, future research, diagnostic tests and technology
More informationHip and Knee Orthopedic Surgical Implants Market Growth, Research & Trend to Radiant Insights, Inc
Hip and Knee Orthopedic Surgical Implants Market Growth, Research & Trend to 2016-2022 Radiant Insights, Inc Orthopedic surgical implants help replace deteriorated joints. This deterioration could be due
More informationU.S. MARKET FOR MINIMALLY INVASIVE SPINAL IMPLANTS
U.S. MARKET FOR MINIMALLY INVASIVE SPINAL IMPLANTS idata_usmis15_rpt Published in December 2014 By idata Research Inc., 2014 idata Research Inc. Suite 308 4211 Kingsway Burnaby, British Columbia, Canada,
More information27 th Annual J.P. Morgan Healthcare Conference. January 13, 2009
27 th Annual J.P. Morgan Healthcare Conference January 13, 2009 1 Forward Looking Statements This presentation and any subsequent Q&A may contain forward-looking statements, including with respect to:»
More informationOBALON THERAPEUTICS, INC. (OBLN) The first and only FDA-approved swallowable, gas-filled intragastric balloon for weight loss
OBALON THERAPEUTICS, INC. (OBLN) The first and only FDA-approved swallowable, gas-filled intragastric balloon for weight loss Forward looking statements Except for statements of historical fact, information
More informationInnovation In Ophthalmics
Innovation In Ophthalmics Ophthalmic Innovation Summit @ AAO 2018 October 25, 2018 Mark Iwicki Chairman & CEO, Kala Pharmaceuticals Disclaimers and Notices This presentation contains forward-looking statements
More information2006 Annual Report. Anastomosis Made Simple
2006 Annual Report R Anastomosis Made Simple Cardica designs and manufactures proprietary automated anastomosis systems used by surgeons to perform rapid, reliable and consistent connections, or anastomoses,
More informationH. LUNDBECK A/S. Teleconference. 10 August PM CET. Financial results Second quarter 2011
H. LUNDBECK A/S Teleconference 10 August 2011-2PM CET Financial results Second quarter 2011 Company disclaimer This presentation contains forward-looking statements that provide our expectations or forecasts
More information37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationFiscal 2019 Annual Meeting of Shareholders December 18, Presentation by Lori Woods, Chief Executive Officer
Fiscal 2019 Annual Meeting of Shareholders December 18, 2018 Presentation by Lori Woods, Chief Executive Officer Safe Harbor Statement Statements in this presentation about IsoRay's future expectations,
More informationHip and Knee Orthopedic Surgical Implants: Market Shares, Strategies, and Forecasts, Worldwide,
Hip and Knee Orthopedic Surgical Implants: Market Shares, Strategies, and Forecasts, Worldwide, 2016-2022 Table of Contents Hip and Knee Orthopedic Surgical Implants: Executive Summary The study is designed
More informationRECLAIM REVISION HIP SYSTEM
RECLAIM REVISION HIP SYSTEM Where Strength and Modularity Connect DESIGN RATIONALE System Overview RECLAIM Modular Revision Hip System WHERE STRENGTH & MODULARITY CONNECT 2 Offset Options Proximal Body
More informationMedia Contact: Ron Rogers Investor Contact: Scott Gleason (801) (801)
News Release Media Contact: Ron Rogers Investor Contact: Scott Gleason (801) 584-3065 (801) 584-1143 rrogers@myriad.com sgleason@myriad.com Myriad Receives FDA Approval of BRACAnalysis CDx as Companion
More informationBuilding a Stroke Portfolio. June 28, 2018
Building a Stroke Portfolio June 28, 2018 1 Forward-Looking Statements This presentation contains forward-looking statements, including statements relating to: the potential benefits, safety and efficacy
More informationInnovation in Medical Technology. BIOTECH GroupG
Innovation in Medical Technology BIOTECH GroupG BIOTECH MULTI-NATIONAL GERMAN - BASED Developer, Manufacturer, Distributor HIP-,, KNEE-,, TRAUMA- SPINE-IMPLANTS IMPLANTS BIOTECH Factories and Offices Plants
More informationAnnual Shareholders Meeting
Annual Shareholders Meeting February 8, 2018 Dow R. Wilson, President and Chief Executive Officer Forward-Looking Statements Except for historical information, this presentation contains forward-looking
More informationDesigning a Smoke-Free Future
Designing a Smoke-Free Future Morgan Stanley Global Consumer & Retail Conference New York, November 14, 2017 Jacek Olczak Chief Financial Officer Martin King President, Asia Region Forward-Looking and
More informationMichael L. Levitz Chief Financial Officer. November 15, 2017 Investor Presentation
Michael L. Levitz Chief Financial Officer November 15, 2017 Investor Presentation Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's expectations, anticipations,
More informationBRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020
BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...
More informationN a s d a q : I N S Y
N a s d a q : I N S Y 0 Safe Harbor Statement This presentation contains both historical information and forward-looking statements. Forward-looking statements are based on management's current expectations
More informationApproach Patients with CONFIDENCE
Design Rationale Approach Patients with CONFIDENCE The ACTIS Total Hip System is the first DePuy Synthes stem specifically designed to be utilized with tissue sparing approaches, such as the anterior
More informationSAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0165BDB Publication Date: January 2013 GlobalData. This report
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.
More informationJames T. Mazzara, MD Continuing Medical Education 10/8/2006
CME Course Sponsor/Location Date Credits Trauma CME Open Fracture and Pelvic Fracture Case Review Hartford Hospital 9/28/2006 1 Orthopedic Department Meeting Hartford Hospital 9/28/2006 1 Multidisciplinary
More informationCorporate Presentation Fourth Quarter 2017
Corporate Presentation Fourth Quarter 2017 November 2017 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationValue creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO
Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO Forward-looking statements The forward-looking statements contained in this presentation,
More informationAsia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
More informationSpinal Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide,
Spinal Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2016-2022 Table of Contents Spinal Surgical Robot: Executive Summary The study is designed to give a comprehensive overview
More informationInvestor Day Lausanne, September 29, Nicholas Rolli Vice President, Investor Relations & Financial Communications
Investor Day Lausanne, September 29, 2016 Nicholas Rolli Vice President, Investor Relations & Financial Communications PMI Investor Relations Mobile Application ("App") / Wi-Fi Access Free app available
More informationTRUMATCH PERSONALIZED SOLUTIONS with the SIGMA High Performance Instruments
TRUMATCH PERSONALIZED SOLUTIONS with the SIGMA High Performance Instruments Resection Guide System SURGICAL TECHNIQUE RESECTION GUIDE SURGICAL TECHNIQUE The following steps are an addendum to the SIGMA
More information4 th Quarter 2017 Earnings Review & Investor Update
4 th Quarter 2017 Earnings Review & Investor Update February 5, 2018 1 Forward-Looking Information This presentation contains statements about the Company s future plans and prospects that constitute forward-looking
More informationSpecializing in Mechanical Testing for Medical Devices. Office:
Specializing in Mechanical Testing for Medical Devices Office: 260.489.1444 Email: sales@jtlamerica.com www.jtlamerica.com Spine Spinal implant test standards can t keep up with the rapid pace of device
More informationEU5 Bariatric Surgery Procedures Outlook to 2020
EU5 Bariatric Surgery Procedures Outlook to 2020 Reference Code: GDMECR0089PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationG7 ACETABULAR SYSTEM. beautifully. efficient.
G7 ACETABULAR SYSTEM beautifully efficient. HERITAGE MEETS MODERN DESIGN SIMPLICITY, EFFICIENCY AND PERFORMANCE The G7 System is a multi-bearing acetabular platform delivering simplicity, efficiency and
More informationThis is a licensed product of Ken Research and should not be copied
1 TABLE OF CONTENTS 1. The US Diabetes Care Devices Market Introduction 1.1. What is Diabetes and it s Types? 2. The US Diabetes Care Devices Market Size, 2007-2013 3. The US Diabetes Care Devices Market
More informationJefferies Healthcare Conference June 6, 2018
Jefferies Healthcare Conference June 6, 2018 Forward-Looking Statements Some of the statements included in this presentation, particularly those regarding the commercialization and ongoing clinical development
More informationZimmer NexGen MIS Tibial Component
Zimmer NexGen MIS Tibial Component Innovative Solutions for Minimally Invasive Procedures Innovative Design for MIS Procedures. The NexGen MIS Tibial Component was designed specifically to address the
More information